Roles of NF-κB in Cancer and Their Therapeutic Approaches / / edited by Véronique Baud.
Although mortality rates have declined in recent years, the majority of cancers are still difficult to treat and the medical need for better cancer treatment is evident. The current anticancer armamentarium includes many active agents that are applied across tumor types. However, most of these broad...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | Basel : : MDPI - Multidisciplinary Digital Publishing Institute,, 2018. |
Year of Publication: | 2018 |
Language: | English |
Physical Description: | 1 online resource (x, 330 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
LEADER | 02502nam a2200289 i 4500 | ||
---|---|---|---|
001 | 993603259104498 | ||
005 | 20230702121208.0 | ||
006 | m o d | ||
007 | cr ||||||||||| | ||
008 | 230702s2018 sz o 000 0 eng d | ||
020 | |a 3-03897-118-9 | ||
035 | |a (CKB)5400000000000203 | ||
035 | |a (NjHacI)995400000000000203 | ||
035 | |a (EXLCZ)995400000000000203 | ||
040 | |a NjHacI |b eng |e rda |c NjHacl | ||
050 | 4 | |a QP552.T68 |b .R654 2018 | |
082 | 0 | 4 | |a 572.8845 |2 23 |
245 | 0 | 0 | |a Roles of NF-κB in Cancer and Their Therapeutic Approaches / |c edited by Véronique Baud. |
264 | 1 | |a Basel : |b MDPI - Multidisciplinary Digital Publishing Institute, |c 2018. | |
300 | |a 1 online resource (x, 330 pages) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
588 | |a Description based on publisher supplied metadata and other sources. | ||
520 | |a Although mortality rates have declined in recent years, the majority of cancers are still difficult to treat and the medical need for better cancer treatment is evident. The current anticancer armamentarium includes many active agents that are applied across tumor types. However, most of these broadly-active anticancer drugs have a small therapeutic index and barely discriminate between malignant and normal cells. In recent years the focus has shifted to the development of rationally designed, molecularly-targeted therapy for the treatment of a specific cancer, therefore offering the promise of greater specificity coupled with reduced systemic toxicity. NF-kB transcription factor family as emerged as such a promising target for cancer therapy. This Special Issue will explore the routes from NF-kB basic research, cancer research and oncogenomics into the development of NF-kB-based cancer therapeutics and biomarkers. We invite research and review papers in any area of the NF-kB field that are related, but not limited to, fundamental understanding of NF-kB signaling pathways, gene expression profiling, epigenetic regulation, diagnostic, prognostic and pharmacogenomic biomarkers, molecular targets driving the progression of human cancers, cancer drug development on these targets, clinical trial with new agents, and validation in animal models. We hope that this Special Issue reflects the exciting era that we are living in with respect to the field of NF-kB and its applications in cancer research. | ||
650 | 0 | |a Transcription factors. | |
650 | 0 | |a Proteins |x Therapeutic use. | |
700 | 1 | |a Baud, Véronique, |e editor. | |
906 | |a BOOK | ||
ADM | |b 2023-07-08 12:18:29 Europe/Vienna |f system |c marc21 |a 2020-10-31 22:37:04 Europe/Vienna |g false | ||
AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5345719570004498&Force_direct=true |Z 5345719570004498 |b Available |8 5345719570004498 |